Drugs / SLAMF7 CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04499339 | Jul 2020 → Dec 2025 | plasma cell myeloma | Wuerzburg University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLAMF7 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04499339 ↗ |
| Modality | Cell therapy | “autologous SLAMF7 CAR-T cells” NCT04499339 ↗ |
| Target | SLAMF7 | “SLAMF7 CAR-T cells” NCT04499339 ↗ |